Alnylam Gets VIP Status as the FDA Slaps Breakthrough Tag on Patisiran Post author:Sam Post published:November 19, 2017 Post category:BioPharma The company is weeks away from completing its rolling NDA for Patisiran. Source: BioSpace You Might Also Like Despite Spike, Why Investors Should Still Avoid MannKind Like the Plague January 30, 2018 More Deaths Lead Seattle Genetics to Discontinue Phase III Leukemia Study June 18, 2017 Targovax: Invitation To First Quarter 2017 Results Presentation Tuesday 25 April April 18, 2017
